Current tests require extraction of cerebrospinal fluid (CSF) in a specialized center or hospital.
Diagnostic methods via positron emission tomography (PET), magnetic resonance imaging (MRI) and lumbar puncture are invasive and expensive.
The current tests are based on the amyloid hypothesis. This most likely excludes a number of factors that determine the clinical manifestation of AD.
